To further elucidate the molecular mechanisms of SPP1 in TAMs, we analyzed publicly available data (GSE230666), which involved the inhibition of SPP1 in HCC-TAMs (shSPP1) along with negative control (shControl) (18). Here, SPP1 is linked to hepatocellular carcinoma.